Submitted for Publication: July 9, 2015; final revision received October 1, 2015; accepted October 3, 2015.
Published Online: November 25, 2015. doi:10.1001/jamaophthalmol.2015.4625.
Study concept and design: Bastawrous, Shah, Kuper, Burton.
Acquisition, analysis, or interpretation of data: All authors.
Drafting of the manuscript: Bastawrous, Shah, Livingstone, Hu.
Critical revision of the manuscript for important intellectual content: Bastawrous, Giardini, Bolster, Peto, Livingstone, Weiss, Rono, Kuper, Burton.
Statistical analysis: Bastawrous, Peto, Weiss, Hu.
Obtained funding: Bastawrous, Burton.
Administrative, technical, or material support: Bastawrous, Giardini, Peto, Shah, Livingstone, Weiss, Rono.
Study supervision: Giardini, Peto, Kuper, Burton.
Conflict of Interest Disclosures: All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.
Funding/Support: The Nakuru Eye Disease Cohort Study was jointly funded by the Medical Research Council (MRC) and the Department for International Development (DFID) under the MRC/DFID Concordat agreement and Fight for Sight. Additional funding supporting the study (equipment and field staff) was provided by the International Glaucoma Association and the British Council for the Prevention of Blindness. Dr Burton is supported by the Wellcome Trust (reference 098481/Z/12/Z). Peek Vision research is funded under the Commonwealth Eye Health Consortium by the Queen Elizabeth Diamond Jubilee Trust.
Role of the Funder/Sponsor: The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and the decision to submit the manuscript for publication.
Additional Contributions: Kevin Wing, PhD, provided statistical analysis, and Peter Blows and Arrianne O’Shea provided statistical analysis. No compensation was provided.